论文部分内容阅读
Adequate screening methods can decrease colorectal cancer(CRC) mortality.The guaiac test for fecal occultblood(FOBT) is part of the German CRC Screening Program since 1970 and has evidence level Ia.In randomized multicenter-studies FOBT has an average sensitivity of 24% and decreases CRC mortality up to 30%.Immunological tests for human haemoglobin(iFOBT) show better performance characteristics than guaiac FOBT,with augmented sensitivity and specificity.However,the single tests show wide differences in diagnostic performance and iFOBT is not yet covered by insurance companies although it should replace the guaiac test for CRC screening.Visual colonoscopy,which was introduced to the German National Cancer Screening Program in 2002,is the gold standard for the diagnosis of colorectal neoplasia.From 2003 to 2007 more than 2.8 million examinations have been documented in Germany.The prevalence of adenomas is around 20% and of CRC about 0.7% to 1.0% of the screenings.Seventy percent of the carcinomas detected during screening are in an early stage(UICCⅠand Ⅱ).Furthermore,screening colonoscopy is a cost saving procedure with a low complication rate(0.25% overall).Insurance companies save 216€ for each screening colonoscopy mainly by prevention of neoplasia due to polypectomy.In Germany,virtual colonography by computed tomography(CT) or magnetic resonance imaging still lacks standardization of the hard and software.In experienced centres the sensitivity for CRC and large polyps of CT colonography is comparable to colonoscopy but in meta-analyses the ranking is lower.New technologies like computer-aided colonoscopies with sheath or double balloon techniques are coming up as well as capsule colonoscopy,which sensitivity for large polyps is about 70%.Advised by his physician,the patient can choose his most acceptable examination method from this whole set of screening tools.
Adequate screening methods can reduce colorectal cancer (CRC) mortality. The guaiac test for fecal occult blood (FOBT) is part of the German CRC Screening Program since 1970 and has evidence level Ia. In randomized multicenter-studies FOBT has an average sensitivity of 24% and decreased decreases in CRC mortality up to 30%. Immunological tests for human hemoglobin (iFOBT) show better performance characteristics than guaiac FOBT, with augmented sensitivity and specificity. Yet, the single tests show wide differences in diagnostic performance and iFOBT is not yet covered by insurance companies although it should replace the guaiac test for CRC screening. Visual colonoscopy, which was introduced to the German National Cancer Screening Program in 2002, is the gold standard for the diagnosis of colorectal neoplasia. From 2003 to 2007 more than 2.8 million examinations have been documented in Germany. The prevalence of adenomas is around 20% and of CRC about 0.7% to 1.0% of the screenings. Seventy percent of the carcinomas detected during screening are in an early stage (UICCⅠand Ⅱ) .Furthermore, screening colonoscopy is a saving procedure with a low complication rate (0.25% overall) .Insurance companies save 216 € for each screening colonoscopy mainly by prevention of neoplasia due to polypectomy.In Germany, virtual colonography by computed tomography (CT) or magnetic resonance imaging still lacks standardization of the hard and software.In experienced centuries the sensitivity for CRC and large polyps of CT colonography is comparable to colonoscopy but in meta-analyzes the first is lower. New technologies like computer-aided colonoscopies with sheath or double balloon techniques are coming up as well as capsule colonoscopy, which sensitivity for large polyps is about 70% .Advised by his physician, the patient can choose his most acceptable examination method from this whole set of screening tools.